Epidemiology of anaphylaxis and biphasic reaction in Japanese children

Kento Ikegawa1,2, Emi Morikawa2,3, Ayako Nigo1

  • 1Department of General Pediatrics Tokyo Metropolitan Children's Medical Center Tokyo Japan.

Insights

Biphasic anaphylaxis reactions occur in 1.7% of pediatric cases, with clinically significant events in 0.3%. Careful monitoring of anaphylaxis patients is crucial due to the regular occurrence of these delayed reactions.

Area of Science:

  • Pediatric Emergency Medicine
  • Allergy and Immunology
  • Clinical Epidemiology

Background:

  • Anaphylaxis is a severe allergic reaction, but its epidemiology and biphasic reaction characteristics are not well-defined.
  • Biphasic anaphylactic reactions in children range from 0.9% to 14.7%, with limited understanding of their specific features and observation duration.

Purpose of the Study:

  • To investigate the epidemiology of anaphylaxis in children.
  • To identify the characteristics of biphasic anaphylactic reactions in pediatric patients.

Main Methods:

  • An observational study was conducted.
  • Data were collected from pediatric emergency department (PED) admissions for anaphylaxis between March 2010 and March 2017.

Main Results:

  • Out of 264,689 children visiting the PED, 353 (0.13%) were hospitalized for anaphylaxis.
  • Six patients (1.7%) experienced biphasic reactions, with a median onset of 5.9 hours after initial symptoms.
  • One patient (0.3%) had a clinically significant biphasic reaction requiring epinephrine.

Conclusions:

  • The incidence of biphasic reactions was 1.7%, and clinically important biphasic reactions were 0.3%.
  • Regular occurrence of biphasic reactions necessitates careful patient monitoring after anaphylaxis.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
29.4K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.1K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
2.5K
Cross-reactivity00:42

Cross-reactivity

Overview
31.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
41
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
45